K2VITAL delivers optimal activation of
the "tri-essentials" - calcium, vitamin D3
and vitamin K2 MK-7 for superior bone health
The health and wellbeing demands of today’s consumer are continually escalating - the quest for optimum childhood development and a longer, more active adulthood is a high priority.
Yet the incidence of negative bone conditions and cardiovascular diseases remains high, inhibiting optimum health across the lifestages:
• The World Health Organisation cites that heart attacks and strokes represent 29% of all global deaths making cardiovascular diseases, one of the most prominent causes of early mortality.
• After 30 years of age, bone mass decreases in both men and women. [Osteoporosis Foundation]
• Osteoporosis is affecting 1 in 3 woman and 1 in 5 men globally with no discrimination based on geographical location. [Osteoporosis Foundation].
Today’s consumers are Vitamin K2 MK-7 deficient and largely unaware of the vital role Vitamin K2 MK-7 can play in supporting an optimum healthy lifestyle. [Reported by Knapen, MH, et al].
Hence, Kappa Bioscience’s aim is to make Vitamin K2 MK-7 available for everybody, everywhere to deliver the best possible bone building and cardiovascular health support and minimise the risk of cardiovascular disease and early mortality.
Read more about K2VITAL®'s health benefits